A new study examines how cost, side effects, and other factors influence whether people stop GLP-1s, while Noom cuts staff to ...

The world's leading insulin manufacturer faces critical decisions as weight-loss drug demand strains production capacity.

Is compounded semaglutide effective for weight loss? Here’s the short version: Compounded semaglutide isn’t approved by the ...

Investors are upset at a lack of clarity over the results of Wegovy successor CagriSema after trials published in December.

Amgen posted a higher quarterly profit on Tuesday as product sales rose 11% and said late-stage studies of key obesity drug ...

Novo Nordisk is under pressure from investors for more information about its next-generation obesity drug candidate CagriSema ...

The AP-NORC survey shows about half of U.S. adults believe it is a good thing for adults to use Ozempic, Wegovy and similar ...

One in ten people in the UK have a needle phobia so serious it means they frequently miss out on vital treatments such as ...

Weight-loss drugs have also now been added to the list of “high-risk” medicines requiring extra safeguards. If pharmacists do ...

Those too slim to be eligible for injections can no longer get prescription without seeing a doctor under new guidance ...

Pharma giant Novo Nordisk, the company behind Wegovy and Ozempic, expects to launch six products in the next five years. Leading the pack of new drugs will be CagriSema.

Physician–scientists at the University of Utah's John A. Moran Eye Center have published an investigatory review of nine ...